Literature DB >> 6377871

Standardization of the immunofluorescence test for autoantibody to nuclear antigens (ANA): use of reference sera of defined antibody specificity.

D P Molden, R M Nakamura, E M Tan.   

Abstract

Standardization of the indirect immunofluorescence antinuclear antibody (IF-ANA) test can be improved for a given substrate with use of reference ANA sera, uniform assay conditions, and standardization of optical systems. To accomplish this, reference sera from the Arthritis Foundation with defined antibody specificities for nDNA, SS-B, RNP, Sm, nucleoli, and "speckled pattern" were reacted with commonly used IF-ANA substrates, mouse kidney sections, KB and HEp-2 tissue culture cells. Reagents and assay conditions used were those provided with the substrates in commercially available IF-ANA kits. A microscope slide with graded intensities of fluorescent beads was used to standardize microscope fluorescence intensity readings. The authors' fluorescence pattern and intensity results should be directly comparable to results obtained in other laboratories for the six antibodies for which reference sera are available. Although no defined sera are widely available for SS-A, Scl-70, PM-1, and centromere antibodies, the ability of each substrate to detect these antinuclear antibodies as well as mitochondrial, smooth muscle, ribosomal and microsomal antibodies also was tested. HEp-2 cells and KB cells were found to be superior to mouse kidney sections for detection of SS-A, Scl-70, PM-1 and centromere antinuclear antibodies. Mouse kidney sections were superior for screening of sera for the absence of ANA as well as for detection of smooth muscle and liver-kidney microsomal antibodies. Other antibodies were detected with equal sensitivity with all substrates and each of the three ANA kits used in the study performed satisfactorily. Use of reference sera as well as optical standardization is recommended for IF-ANA testing.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6377871     DOI: 10.1093/ajcp/82.1.57

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

1.  Relation between serological data at the time of biopsy and renal histology in lupus nephritis.

Authors:  J C Nossent; S C Henzen-Logmans; T M Vroom; V Huysen; J H Berden; A J Swaak
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

2.  Precise quantitation of antinuclear antibodies on HEp-2 cells without the need for serial dilution.

Authors:  P N Hollingsworth; R I Dawkins; J B Peter
Journal:  Clin Diagn Lab Immunol       Date:  1996-07

3.  Standardisation of the quantitative determination of antinuclear antibodies (ANAs) with a homogeneous pattern.

Authors:  T E Feltkamp; F Klein; M B Janssens
Journal:  Ann Rheum Dis       Date:  1988-11       Impact factor: 19.103

4.  Use of cultured epithelial cells, including keratinocytes, for the detection of antinuclear antibodies.

Authors:  I Leigh; F Wojnarowska; S Burge; B Bhogal; T Zhu
Journal:  Ann Rheum Dis       Date:  1987-12       Impact factor: 19.103

5.  Screening test for rheumatic diseases: a combined enzyme immunoassay of rheumatoid factors and antibodies to DNA and extractable nuclear antigens.

Authors:  P Kurki; M Gripenberg; P Partanen; T Helve
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

6.  C-reactive protein is essential for innate resistance to pneumococcal infection.

Authors:  J Paul Simons; Jutta M Loeffler; Raya Al-Shawi; Stephan Ellmerich; Winston L Hutchinson; Glenys A Tennent; Aviva Petrie; John G Raynes; J Brian de Souza; Rachel A Lawrence; Kevin D Read; Mark B Pepys
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

7.  Prevalence of autoantibodies against cellular antigens in patients with HIV and leprosy coinfection in the Amazon region.

Authors:  Clea Nazaré Carneiro Bichara; Carlos David Araújo Bichara; Camila Tostes; Marinete Marins Povoa; Juarez Antonio Simões Quaresma; Marília Brasil Xavier
Journal:  Infect Dis Poverty       Date:  2017-06-01       Impact factor: 4.520

8.  Different indirect immunofluorescence ANA substrate performance in a diagnostic setting of patients with SLE and related disorders: retrospective review and analysis.

Authors:  May Y Choi; Jing Cui; Karen Costenbader; David Rydzewski; Lisa Bernhard; Peter Schur
Journal:  Lupus Sci Med       Date:  2020-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.